15 Days Price Change
Closing In
WEBSITE Inc. Year: 2020 Industry: Pharmaceuticals & Drugs Listed Page
Buy unlisted shares early and participate in the growth before public listing.
Company Promoters
Pre Issue Share Holding 99.86%
Post Issue Share Holding 73.53%
Listing Price: 132.5
Listing Gain: 27.55%
Current Price: 250.2
Gain On Issue: 250.2 | 0%
GMP: --
GMP %: -- %
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | 115,200 |
| Retail (Max) | 1 | 1200 | 115,200 |
| S-HNI (Min) | 2 | 2400 | 230,400 |
| S-HNI (Max) | 8 | 9600 | 921,600 |
| B-HNI (Min) | 9 | 10800 | 1,036,800 |
1. Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division. 2. Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division. 3. Purchase of Machineries for Homecare and Cosmetic Division. 4. General Corporate Purposes.
| Category | Nos | Bid | Bid (x) |
|---|---|---|---|
| QIB | 0 | 159818400 | 0x |
| NII | 0 | 418878000 | 0x |
| Retail | 0 | 238842000 | 0x |
| EMP | 0 | 0 | 0x |
| Total | 0 | 817538400 | 0x |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 5% | 21% | 0% | 0% |
| Operating Profit CAGR | 24% | 52% | 0% | 0% |
| PAT CAGR | 18% | 48% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 45% | 66% | 75% | 75% |
| ROCE Average | 60% | 86% | 94% | 94% |
Influx Healthtech Ltd.
Atul Kumar Ashok Kumar Shukla
+91 7045997809
Influx Healthtech Ltd.
Rarever Financial Advisors Pvt Ltd.
Influx Healthtech Ltd.
Maashitla Securities Pvt Ltd.
451, Krishna Apra Business Square, Netaji Subhash Place, Pitampura, New Delhi – 110034
When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.
For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.
Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.
Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.
Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.
ChatGPT
Claude
Perplexity
